807 A vaccine targeting the recurrent driver mutation H3K27M induces mutation specific T- and B- cell responses in patients with diffuse midline Gliomas

• Isabel Poschke,
• Michael Platten,
• Edward Green,
• Katharina Lindner,
• Tamara Boschert,
• Taga Lerner,
• Kristina Kromer,
• Iris Mildenberger,
• Gordon Haltenhof,
• Katharina Sahm,
• John Lindner

Affiliations

Isabel Poschke

1German Cancer Research Center (DKFZ), Heidelberg, Germany

Michael Platten

3DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany

Edward Green

1German Cancer Research Center (DKFZ), Heidelberg, Germany

Katharina Lindner

6DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany

Tamara Boschert

1German Cancer Research Center (DKFZ), Heidelberg, Germany

Taga Lerner

5BioMed X Innovation Center, Heidelberg, Germany

Kristina Kromer

5BioMed X Innovation Center, Heidelberg, Germany

Iris Mildenberger

4Department of Neurology, Medical Faculty Mannheim, MCTN Heidelberg University, Mannheim, Germany

Gordon Haltenhof

1German Cancer Research Center (DKFZ), Heidelberg, Germany

Katharina Sahm

German Cancer Consortium (DKTK), Clinical Cooperation Unit (CCU), Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany

John Lindner

5BioMed X Innovation Center, Heidelberg, Germany